Ascendis Pharma A/S vs Atmos Energy Corporation — how do they compare? Ascendis Pharma A/S trades at $254.5 (market cap $16.67B), while Atmos Energy Corporation trades at $168.76 (market cap $28.59B). The key difference: Atmos Energy Corporation is the larger of the two by market cap, and Atmos Energy Corporation pays a 2.36% dividend while Ascendis Pharma A/S pays none. Which is the better fit depends on your goals.
| ASND | ATO | |
|---|---|---|
Market Cap | $16.67B | $28.59B |
Sector | Health | Utilities |
52-Week High | $277.18 | $192.25 |
52-Week Low | $189.74 | $162.44 |
Enterprise Value | $17.04B | $38.40B |
Dividend Yield | — | 2.36% |
Trailing returns across standard periods
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →Atmos Energy is the largest publicly traded, fully regulated, pure-play natural gas utility in the United States, serving more than 3 million customers in Texas, Colorado, Kansas, Kentucky, Louisiana, Mississippi, Tennessee, and Virginia. About two thirds of its earnings come from Texas, where it distributes natural gas in northern Texas and owns an intrastate gas pipeline spanning several key shale gas formations and interconnected with five storage facilities.
Read more on ATO →